# Frank Bulens

> Frank Bulens is a seed investor at imec.xpand (Leuven) backing Health Care and Medical Device. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [imec.xpand](https://shizune.co/investors/profile/imec-xpand)
- Location: Leuven, Belgium
- Total investments: 6
- Last investment: Oct 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/frankbulens

Frank Bulens is a seed investor at imec.xpand in Leuven focused on Health Care and Medical Device. Frank Bulens is based out of Leuven, Vlaams-Brabant, and is the partner of imec.xpand. Frank previously worked at Indigo as a board member. Frank Bulens attended KU Leuven.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 50% |
| Medical Device | 3 | 50% |
| Biotechnology | 2 | 33% |
| Life Science | 1 | 17% |
| Neuroscience | 1 | 17% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 33% |
| Series A | 2 | 33% |
| Series B | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Belgium | 2 | 33% |
| Spain | 1 | 17% |
| Ireland | 1 | 17% |
| Switzerland | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| INBRAIN Neuroelectronics | INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. | $49.8M | Series B | Oct 29, 2024 |  |
| LUMA Vision | OneProjects is an Irish-German cardiac imaging specialist. | $21.8M | Series A | Dec 18, 2023 |  |
| Nagi Bioscience | Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology. | $14.5M | Series A | Sep 28, 2023 |  |
| Axithra | Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood. | $10.7M | Seed | Sep 05, 2023 |  |
| LUMA Vision | OneProjects is an Irish-German cardiac imaging specialist. | $8M | Series A | Oct 14, 2021 |  |
| Azalea Vision | Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders. | $7.3M | Seed | Jul 08, 2021 |  |

6 of 6 investments shown.

## Co-investors
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 2 deals together
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 2 deals together
- [Aliath Bioventures](https://shizune.co/investors/profile/aliath-bioventures) — VC Fund, 1 deal together
- [Asabys Partners](https://shizune.co/investors/profile/asabys-partners) — VC Fund, 1 deal together
- [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge) — VC Fund, 1 deal together
- [Atlantic Bridge University Fund](https://shizune.co/investors/profile/atlantic-bridge-university-fund) — VC Fund, 1 deal together

## About imec.xpand

VC Fund · Leuven, Belgium

Imec.xpand is an independently managed, game-changing way to enable early-stage nano electronics-based innovation powered by imec, the world-leading R&D hub for nanoelectronics and digital technology.

3 contacts available at imec.xpand.

| Name | Title | Profile |
| --- | --- | --- |
| Frank Bulens | Partner | https://shizune.co/investors/profile/frank-bulens |
| Tom Vanhoutte | Partner, Founder & Managing Partner | https://shizune.co/investors/profile/tom-vanhoutte |
| Cyril Vancura | Partner | https://shizune.co/investors/profile/cyril-vancura |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Frank Bulens invest in?

Frank Bulens invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Frank Bulens last invest?

The most recent investment recorded for Frank Bulens closed in Oct 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co